FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LUVIXASERTIB
异名/同义词BENZAMIDE, N-CYCLOPROPYL-4-(7-(((CIS-3-HYDROXY-3-METHYLCYCLOBUTYL)METHYL)AMINO)-5-(3-PYRIDINYLOXY)PYRAZOLO(1,5-A)PYRIMIDIN-3-YL)-2-METHYL-
CFI402257
CFI-402257
LUVIXASERTIB
LUVIXASERTIB [INN]
N-CYCLOPROPYL-4-(7-((((1S,3S)-3-HYDROXY-3- METHYLCYCLOBUTYL)METHYL)AMINO)-5-((PYRIDIN-3- YL)OXY)PYRAZOLO(1,5-A)PYRIMIDIN-3-YL)-2- METHYLBENZAMIDE
N-CYCLOPROPYL-4-(7-(((CIS-3-HYDROXY-3-METHYLCYCLOBUTYL)METHYL)AMINO)-5-(3-PYRIDINYLOXY)PYRAZOLO(1,5-A)PYRIMIDIN-3-YL)-2-METHYLBENZAMIDE
CAS登记号1610759-22-2
物质唯一标识(Unique Ingredient Identifier)HE97PTK3Q6
分子式C28H30N6O3
国际化合物标识(International Chemical Identifier,InChI)PMQUGSPFUBGJCZ-CHOKWEPUSA-N
SMILESC(Nc1n2c(nc(c1)Oc3cnccc3)c(-c4ccc(c(C)c4)C(NC5CC5)=O)cn2)[C@@H]6C[C@](O)(C6)C
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System